Since the discovery by Fujiwara and coworkers that this residue was selectively and extensively phosphorylated in synucleinopathy lesions [26], antibodies for phosphorylated alpha-synuclein have been widely used to label LTS in the central nervous system as well as in peripheral autonomic networks including the enteric nervous system [3, 9]. Here, SNCA is linked to synucleinopathy.